Rx Spending Growth To Be Driven By New Drug Entries CMS Says
Rx Spending Growth To Be Driven By New Drug Entries, CMS Says
15:22 EST 20 Feb 2019 |
SCRIP
Advances in cancer, diabetes, and Alzheimer's could lead to expensive new treatments, contributing to spending increases in next decade, according...
Original Article: Rx Spending Growth To Be Driven By New Drug Entries, CMS Says
More From BioPortfolio on "Rx Spending Growth To Be Driven By New Drug Entries, CMS Says"